Gujarat Themis Biosyn Limited (BOM:506879)
India flag India · Delayed Price · Currency is INR
359.70
-29.55 (-7.59%)
At close: Nov 16, 2026

Gujarat Themis Biosyn Income Statement

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
1,8421,6581,5081,6981,4841,149
Revenue Growth
18.45%9.96%-11.20%14.45%29.20%26.82%
Cost of Revenue
657.96582.8593.2687.4573.39181.25
Gross Profit
1,1841,075914.81,011910.46967.29
Selling, General & Admin
203.49176.99137.35128.6889.4271.99
Other Operating Expenses
344.94141.9280.3795.0476.04307.64
Operating Expenses
712.81448.1271.47259.08191.22401.96
Operating Income
470.78627.33643.33751.75719.25565.33
Interest Expense
-126.58-25.98-2.33-1.43-0.95-6.56
Interest & Investment Income
9.139.137.1240.3551.2932.61
Currency Exchange Gain (Loss)
1.571.570.530.23-0.09
Other Non Operating Income (Expenses)
8.858.856.732.455.06-1.13
EBT Excluding Unusual Items
363.75620.9655.38793.34774.65590.35
Other Unusual Items
-11.74-----
Pretax Income
352.02620.9655.38793.34774.65590.35
Income Tax Expense
146.22154.09167.66201.71194.96154.1
Net Income
205.79466.82487.72591.63579.69436.24
Net Income to Common
205.79466.82487.72591.63579.69436.24
Net Income Growth
-57.39%-4.29%-17.56%2.06%32.88%44.55%
Shares Outstanding (Basic)
110109109109109109
Shares Outstanding (Diluted)
110109109109109109
Shares Change
1.03%-----
EPS (Basic)
1.874.284.485.435.324.00
EPS (Diluted)
1.874.284.485.435.324.00
EPS Growth
-57.92%-4.38%-17.56%2.06%32.88%44.57%

Additional Metrics

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Free Cash Flow
-1,478-1,238-251.22-104.32157.74264.16
Free Cash Flow Per Share
-13.44-11.36-2.31-0.961.452.42
Dividend Per Share
0.6700.6700.6701.0000.7200.800
Dividend Growth
0%0%-33.00%38.89%-10.00%-
Gross Margin
64.27%64.85%60.66%59.52%61.36%84.22%
Operating Margin
25.56%37.83%42.66%44.27%48.47%49.22%
Profit Margin
11.18%28.15%32.34%34.84%39.07%37.98%
Free Cash Flow Margin
-80.28%-74.63%-16.66%-6.14%10.63%23.00%
EBITDA
621.82743.18684.2775.58737.48580.14
EBITDA Margin
33.77%44.82%45.37%45.67%49.70%50.51%
D&A For EBITDA
151.03115.8540.8823.8318.2414.81
EBIT
470.78627.33643.33751.75719.25565.33
EBIT Margin
25.56%37.83%42.66%44.27%48.47%49.22%
Effective Tax Rate
41.54%24.82%25.58%25.42%25.17%26.10%
Revenue as Reported
1,8661,6831,5321,7421,5501,189
Advertising Expenses
-0.110.070.16--